Tuberculosis Rapid Test Device

Call For Pricing.

Model Number: NH-52213

Brand: Niche Healthcare

The Tuberculosis Rapid Test Device (Whole Blood/Serum/Plasma) is a rapid chromatographic immunoassay for the qualitative detection of anti-TB antibodies (Isotypes IgG, IgM and IgA) in whole blood, serum or plasma specimens.

 

Description

Catalog No. TB-4012 Format Device
Specimen Whole Blood/Serum/Plasma Certificate CE
Reading Time 15 minutes Test/Kit 40
Storage Temperature 4-30°C Shelf Life 2 Years
Sensitivity >99.9% Specificity >99.9%
Accuracy >99.9% Composition Test device, Dropper, Package insert, Buffer, Desiccant

 

The Tuberculosis (TB) Rapid Test Device (Whole Blood/Serum/Plasma) can offer several healthcare benefits in the National Health Service (NHS) or any healthcare system. Here are potential benefits:

  1. Early Detection of TB Infection: The rapid test allows for the early detection of Mycobacterium tuberculosis (TB) antigens or antibodies in whole blood, serum, or plasma, enabling timely diagnosis of TB infection.

  2. Prompt Initiation of Treatment: Early detection facilitates the prompt initiation of antimicrobial treatment for TB, improving the chances of successful management and reducing the risk of complications associated with untreated or late-treated TB, such as the spread of the disease and severe pulmonary damage.

  3. Prevention of TB Transmission: Identifying individuals with active TB through screening can help in implementing appropriate measures to prevent the transmission of the bacteria to others in healthcare settings and the community.

  4. Identification of Latent TB Infections: Rapid tests can aid in identifying individuals with latent TB infections, allowing for preventive treatment to reduce the risk of progression to active TB.

  5. Screening High-Risk Populations: Rapid tests are valuable for screening high-risk populations, such as individuals with a history of close contact with TB patients, healthcare workers, and individuals living in areas with a high prevalence of TB.

  6. Resource Optimization: Rapid tests contribute to efficient resource utilization by providing quick and cost-effective diagnostic information, allowing healthcare providers to prioritize and manage TB cases more effectively.

  7. Point-of-Care Testing: Rapid tests can be performed at the point of care, providing quick results without the need for sending samples to a laboratory. This expedites decision-making and allows for immediate counseling and treatment initiation.

  8. Public Health Surveillance: Monitoring the prevalence of TB infections in the population through rapid testing can contribute to public health surveillance efforts. This information helps in planning and implementing preventive measures and public health interventions.

  9. Reduction of Stigma: Early diagnosis through rapid testing may contribute to reducing the stigma associated with TB, as individuals can be informed and supported promptly.

 

Infectious Disease Trials

Infectious disease trials are conducted to address various aspects related to the prevention, treatment, and understanding of diseases caused by infectious agents, such as bacteria, viruses, parasites, or fungi. Here are some reasons for conducting infectious disease trials:

  1. Vaccine Development: Trials are crucial for testing the safety and efficacy of new vaccines aimed at preventing infectious diseases. This includes vaccines for viruses like influenza, human papillomavirus (HPV), and emerging threats like COVID-19.
  2. Antiviral and Antibiotic Testing: Clinical trials assess the effectiveness of new antiviral medications or antibiotics in treating infections. This is particularly important in addressing antibiotic resistance and finding alternative treatments.
  3. Understanding Disease Mechanisms: Trials help researchers understand the mechanisms of infectious diseases, including how pathogens spread, evade the immune system, and cause illness.
  4. Global Health Concerns: Trials play a vital role in addressing global health concerns, such as emerging infectious diseases (e.g., Ebola, Zika, COVID-19) and ongoing challenges like malaria, tuberculosis, and HIV.
  5. Public Health Interventions: Trials evaluate the effectiveness of public health interventions, such as strategies for disease prevention, control, and containment.
  6. Drug and Treatment Development: Researchers conduct trials to develop and test new drugs or treatment regimens for infectious diseases, aiming to improve outcomes for affected individuals.
  7. Surveillance and Epidemiology: Clinical trials contribute to surveillance efforts by providing data on disease prevalence, transmission patterns, and the effectiveness of control measures.

Infectious disease trials are essential for advancing our understanding of these diseases, developing effective interventions, and ultimately improving global public health. They contribute significantly to the development of evidence-based strategies for preventing, treating, and managing infectious diseases.

 

Types of Infections

Types of Infections

 

For more information, contact us 01274 965089 or check out our website at www.nicheofficesolutions.co.uk www.nicheofficesolutions.co.uk/niche-nhs

Further clinical information can be found on our blog page: www.nicheofficesolutions.co.uk/category/niche-healthcare-news

For products not found on our online website, please view our Healthcare catalogues: www.nicheofficesolutions.co.uk/healthcare-catalogues

View our Healthcare YouTube videos Playlist

If you have any additional questions, drop us an email at info@nicheofficesolutions.co.uk 

Reviews

There are no reviews yet.

Be the first to review “Tuberculosis Rapid Test Device”